MedPath

The Benefits of Virtual Reality in the Care of Elderly People With Psychomotor Disadaptation Syndrome

Not Applicable
Recruiting
Conditions
Psychomotor Disadaptation Syndrome
Registration Number
NCT07026890
Lead Sponsor
Centre Hospitalier Universitaire Dijon
Brief Summary

Psychomotor Disadaptation Syndrome (PMDS) is characterised by a deterioration in postural function, gait and psychomotor automatisms in the elderly. It is often associated with falls and can manifest itself as retropulsion, gait abnormalities, neurological disorders and psycho-behavioural problems. For the majority of these patients, a stay in a geriatric medical and rehabilitation centre is necessary, enabling an objective assessment of these disorders and multi-professional care, including physiotherapists, occupational therapists and adapted physical activity teachers, aimed at restoring safe movement and motor independence. However, rehabilitation relies on traditional exercises that are limited, repetitive and sometimes far removed from everyday activities. Technological innovations such as virtual reality (VR) offer opportunities to improve care by creating immersive environments that reproduce real-life situations. VR could thus help to rehabilitate the motor problems associated with MS.

The aim of the VIR-AGE project is to study the clinical benefits of VR in the rehabilitation of hospitalised elderly people suffering from PMDS in terms of functional deficits, particularly motor deficits.

The study will take place at the Centre gériatrique Champmaillot of the CHU Dijon Bourgogne. A total of 50 patients with SPDM will take part.

The total duration of your participation is 5 weeks.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Person who has given written consent
  • Person aged ≥ 65 years;
  • With a proven diagnosis of motor maladjustment syndrome;
  • Hospitalised in a geriatric care unit;
  • Able to understand a simple instruction and answer a closed question;
Exclusion Criteria
  • Person not affiliated to or not benefiting from a social security scheme
  • Person subject to a legal protection measure (curatorship, guardianship)
  • Person subject to a judicial protection measure
  • An adult who is incapable or unable to give consent
  • Persons with epilepsy, kinetosis or known claustrophobia Persons unable to understand simple instructions for carrying out tests
  • Anyone with a severe visual and/or hearing impairment
  • Any person with a behavioural disorder (agitation, aggressiveness)
  • Any person with a severe walking or balance problem that makes motor exercises unsuitable
  • Anyone with a pathology, injury, wound or severe deformity to the head or cervical spine
  • Any person suffering from severe vertigo, diagnosed at the discretion of the investigating doctor
  • Inability to use arm for pointing
  • Persons susceptible to migraines
  • Non-French speakers
  • Anyone with an inter-pupillary distance outside the range of possible helmet adjustments

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in 'Timed Up and Go' time between initial and final assessment5 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHU Dijon Bourgogne

🇫🇷

Dijon, France

CHU Dijon Bourgogne
🇫🇷Dijon, France
Mathieu GUEUGNON
Contact
0380293571
mathieu.gueugnon@chu-dijon.fr

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.